Immunochemical characterization and radioimmunometric petection of molecules shed by human ovarian cancer
- 15 November 1987
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 40 (5), 592-597
- https://doi.org/10.1002/ijc.2910400503
Abstract
Monoclonal antibodies (MAbs) OC125, MOv2 and MOv8 recognize the CA125, CAMOv2 and CAMOv8 epitopes, respectively, which are associated with human ovarian carcinomas and are shed by these tumors. The biochemical analysis of the recognized antigens and epitopes has been performed to investigate the possibility of exploiting their expression, if any, on the same molecules. Cross‐competition experiments clearly indicated that the 3 epitopes are distinct. Biochemical analysis was performed on a cyst fluid from an ovarian cystadenoma. Heat treatment and periodate oxidation indicated that CAMOv2 and CAMOv8 are saccharidic and suggested that CA125 is a conformational epitope to which both saccharides and the protein backbone could contribute. By gel‐filtration chromatography CA125 activity was eluted into 2 peaks of high molecular weight, whereas CAMOv2 and CAMOv8 activities were associated with a single broad peak which included CA125‐positive fractions. Isopycnic centrifugation showed that CA125, CAMOv2 and CAMOv8 carrying molecules had the same high density (1.46 g/ml) in the first peak, whereas CA125 molecules had a lower density (1.41 g/ml) in the second peak. Double‐determinant immunoradiometric assays, carried out using different combinations of the MAbs, indicated that in the cyst fluid molecules expressing both CAMOv2 and CAMOv8 could be detected, whereas CA125 was carried by different molecules. CAMOv2 and CA125 could however be expressed on the same molecule in 2 out of 9 ascitic fluids from ovarian carcinoma patients. Taken together, these data indicate that CA125 and CAMOv2‐CAMOv8 were only occasionally expressed on the same molecules. Therefore, the use of the CA125‐CAMOv2 combination could not increase the sensitivity achievable by using each respective simultaneous immunoradiometric assay.This publication has 24 references indexed in Scilit:
- Co‐expression of human cancer‐associated epitopes on mucin moleculesInternational Journal of Cancer, 1987
- Carbohydrate Epitope Defined by an Antitumor Monoclonal Antibody Detected on Glycoproteins and a Glycolipid by ImmunoblottingHybridoma, 1986
- Multiple epitopes on a human breast‐carcinoma‐associated antigenInternational Journal of Cancer, 1985
- Ca 125 and Ca 19–9: two cancer‐associated sialylsaccharide antigens on a mucus glycoprotein from human milkEuropean Journal of Biochemistry, 1985
- Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigensNature, 1985
- Production and Characterization of Monoclonal Antibody to a 60-kD Glycoprotein in Ovarian Carcinoma1Hybridoma, 1985
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.JCI Insight, 1981
- Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-SepharoseImmunochemistry, 1978
- Kinetics of two-site immunoradiometric (‘sandwich’) assays—IIImmunochemistry, 1978